Stock Exchange of Thailand With respect to the financial information for the 2nd quarter ended 30 June 2020, as submitted by the Company, which has been audited by the external auditor, considered by the

, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company

September 30, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For nine months ended September 30, 2019 Overall Group Performance

approving 535,436, Company amendme registered 4, 2019 Notificatio of the Da Capital by Director a The Stock re 1. Capita 2. Inform Existin As Nation s’ Meeting No d the significa 1. Resolv g the decreas

ผลิต รวมในประเทศ ท้าให้กดดันต่ออัตราการท้าก้าไรของผลิตภัณฑ์เมทิลเอสเทอร์ ประกอบกับราคาน ้ามันปาล์มดิบท่ีปรับลดลง จึง ท้าให้กลุ่มธุรกิจเมทิลเอสเทอร์ได้รับผลกระทบจาก Stock Loss & NRV นอกจากนี บริษัทฯ ยัง

, 2020, the market price was continuously decreased which led to higher cost of by-products. Therefore, the Company has realized its stock loss (NRV) of by- product inventories to 1.00 million Baht. 2

this transaction date. The acquisition of IGE shares is classified as Class 1 transaction equal to or higher than 50% but lower than 100% according to the Notification of the Capital Market Supervisory

effectiveness of pandemic control and vaccine development, the economic damage may be worse than what was seen during the 1997 financial crisis. Given volatility in the financial market and real sector which had

February 18, 2019 To: The President The Stock Exchange of Thailand Re: 2018 operating results We, Delta Electronics (Thailand) Public Company Ltd, would like to notify the Company’s 2018 operating

Stock Exchange of Thailand Attachment: Management Discussion and Analysis ended 31 March 2019 As Golden Lime Public Company Limited (“the Company”) has submitted the Auditor’s report on the Consolidated